The global medical food market is anticipated to grow at a significant CAGR during the forecast period. The rate of adoption of medical food to cure diseases naturally is rising rapidly which in turn is anticipated to surge the global medical food industry. The US Food and Drug Administration (FDA) defines medical food in its Orphan Drug Act as “a food which is formulated to be consumed or administered enterally under the supervision of a physician. It is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation”.
Medical foods are not intended to replace traditional drugs. Instead, they’re used as a supplement that aids in supporting the patient’s treatment regimen. Medical food products cannot be counted as traditional drugs, and yet they are stronger than vitamins and dietary supplements already available in the market.
Browse the full report description of "Global Medical Food Market Size, Share & Trends Analysis Report by Type (Pills, Powder, and Others) By Application (Chronic kidney disease, Diabetic Neuropathy, Attention Deficit Hyperactivity Disorder (ADHD), Depression, Nutritional Deficiency, and Others), By Route of Administration (Oral and Enteral), and Forecast 2019-2025" at https://www.omrglobal.com/industry-reports/medical-food-market
The company named Accera is focused on producing medical food for central nervous system disorders such as Alzheimer’s disease and Parkinson’s diseases. Many clinical studies have shown a positive result for their product called Axona that is intended to improve the cognitive functioning and memory to a significant level of the patient with mild to moderate Alzheimer’s disease. Axona acts on the basic cause of Alzheimer’s disease that is the reduced ability to properly metabolize glucose by making the liver produce extra ketones which will act as an alternative energy source. Such efforts by the players give a boost to the growth of the global medical food market.
Many medical foods available commercially are formulated to treat hematological abnormalities such as nonhematologic genetic diseases, sickle cell anemia, and conditions of malabsorption which include Crohn’s disease, ulcerative colitis, and gastro esophageal reflux disease. Numerous companies across the globe are working on the formulation of medical food to treat most of the diseases without the use of medicine. With the increasing production and adoption of medical foods for the incurable disease, the medical food market is also increasing across the globe.
Medical Food Market- Segmentation
By Type
By Application
By Route of Administration
Medical Food Market – Segment by Region
North America
Europe
Asia-Pacific
Rest of the World